Skip to main content

Table 3 PFAS concentrations (ng mL−1) measured in serum samples collected from Faroese whaling men (M, n = 10), children (C, n = 51), and women (W, n = 51) between 2004-07

From: Can profiles of poly- and Perfluoroalkyl substances (PFASs) in human serum provide information on major exposure sources?

Analyte Detection Frequency (%) Median Range
  M C W M C W M C W
nPFOS 100 100 100 47.8 9.82 5.59 12.66–76.04 4.40–15.0 1.84–13.8
brPFOS 100 100 100 22.4 6.38 3.43 8.13–28.83 3.39–11.6 0.86–9.08
PFHxS 100 100 100 2.38 5.94 0.5 0.53–3.71 3.59–14.3 0.15–1.35
PFUnDA 100 100 100 3.13 0.45 0.28 0.71–6.51 0.05–1.7 0.05–1.06
PFNA 100 100 100 3.76 1.24 0.76 1.14–7.39 0.56–3.58 0.35–2.37
PFOA 100 100 100 3.46 0.73 1.0 2.79–5.36 0.34–1.97 0.35–3.1
PFDA 100 100 100 1.85 0.41 0.32 0.48–2.91 0.15–1.1 0.14–1.06
PFHpS 100 90 86 0.65 0.28 0.09 0.16–1.06 <LOD - 0.65 <LOD - 0.22
PFDoDA 100 20 2 0.27 0.07 0.05 0.06–0.65 <LOD - 0.11 <LOD - 0.05
N-MeFOSAA 100 100 92 0.18 0.18 0.1 0.07–0.38 0.06–0.59 <LOD - 0.21
PFHpA 60 90 6 0.39 0.18 0.05 <LOD - 0.49 <LOD - 0.92 <LOD - 0.12
N-EtFOSAA 90 100 18 0.08 0.43 0.07 <LOD - 0.63 0.06–3.05 <LOD - 0.45
nFOSA 80 14 14 0.08 0.07 0.05 <LOD - 0.34 <LOD - 0.17 <LOD - 0.1
PFDS 60 12 27 0.07 0.04 0.06 <LOD - 0.09 <LOD - 0.05 <LOD - 0.13
brFOSA 90 14 12 0.02 0.02 0.01 <LOD - 0.05 <LOD - 0.03 <LOD - 0.01
15 PFASs     87.8 26.2 12.9 26.9–129.1 16.3–39.4 5.01–25.9